Clinical Trials on Hemorrhagic Fevers, Viral

Total 30668 results

London School of Hygiene and Tropical Medicine

Not yet recruiting

Booster Vaccine for Yellow Fever (BoVY)

Yellow Fever
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Sanofi Pasteur, a Sanofi Company

Completed

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

Yellow Fever

Korea, Republic of
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Immunity After Two Doses of Yellow Fever Vaccine (IATDYFV)

Yellow Fever

Brazil
Epicentre
Kenya Medical Research Institute

Completed

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) (YEFE)

Yellow Fever

Uganda, Kenya
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating an Ebola and a Marburg Vaccine in Uganda

Ebola Virus Disease | Marburg Virus Disease

Uganda
Leiden University Medical Center
The International Society of Travel Medicine

Recruiting

Yellow Fever Human Infection Model With YF-17D (YF-INFECT)

Yellow Fever

Netherlands
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
Centers for Disease Control and Prevention
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Infectious...

Unknown

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Yellow Fever
Oswaldo Cruz Foundation

Unknown

Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children

Yellow Fever

Brazil
GE Healthcare

Completed

Trial of Yellow Fever Inactivated Vaccine

Yellow Fever

United States
Rockefeller University
Emory University

Completed

Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults

Yellow Fever

United States
Ilocos Training and Regional Medical Center

Not yet recruiting

Effectiveness Of High Dose Melatonin As Adjunctive Therapy For Dengue Fever With Warning Signs

Dengue Fever With Warning Signs
Tulane University
Merck Sharp & Dohme LLC; Kenema Government Hospital

Not yet recruiting

REVIVE (Response to the Ebola Virus Vaccine)

Ebola Virus Disease

Sierra Leone
Auro Vaccines LLC
United States Department of Defense; Accelovance

Completed

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Ebola Virus Disease

United States
Emory University
Washington University School of Medicine; Merck Sharp & Dohme LLC

Not yet recruiting

Immunology of Ebola Vaccine

Ebola Virus Disease

United States
Singapore General Hospital
Duke-NUS Graduate Medical School; 60 Degrees Pharmaceuticals LLC

Withdrawn

Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore

Dengue Fever

Singapore
Inviragen Inc.

Completed

Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever

Dengue Fever

Colombia
Implicit Bioscience

Withdrawn

IC14 in Adult Patients With Dengue Fever

Dengue Fever
Guangzhou 8th People's Hospital

Unknown

Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou

Dengue Fever

China
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

Celgosivir as a Treatment Against Dengue (CELADEN)

Dengue Fever

Singapore
Cerus Corporation

Terminated

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Acute Ebola Virus Disease

United States
Centre Hospitalier Universitaire de la Réunion

Recruiting

Prospective Study on the Risks of Dengue Fever for the Fetus. (ERiDenF)

Dengue Fever

France
Serum Institute of India Pvt. Ltd.
PPD Australia Pty Ltd

Completed

A Phase 1 Safety Study of Dengusiil in Healthy Adults

Prevention of Dengue Fever

Australia
Karius, Inc.
Tribhuvan University, Nepal

Completed

Detection of Dengue Virus in Plasma of Patients in Nepal

Dengue Fever

Nepal
Timothy Gleeson
Angkor Hospital for Children

Completed

Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue Fever

Fever | Dengue

Cambodia
St. Jude Children's Research Hospital

Completed

Diagnosis and Characterization of Dengue Fever in Children

Dengue Fever

United States, El Salvador
Postgraduate Institute of Medical Education and...

Completed

Role of Andi-d in Dengue Fever: a Pilot Study

Dengue Fever

India
London School of Hygiene and Tropical Medicine

Completed

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Hiv | Ebola Virus Disease | Ebola

Kenya, Uganda
Oregon Health and Science University

Recruiting

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

Yellow Fever | Immunization; Infection

United States
Centre Hospitalier Universitaire de la Réunion

Active, not recruiting

Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island (DENGUE-RUN)

Dengue Fever With Warning Signs

France
Indonesia University

Unknown

Resuscitation With Albumin 5% in Dengue Haemorrhagic Fever

Dengue Hemorrhagic

Indonesia
National Institute of Allergy and Infectious Diseases...
Institut National de la Santé Et de la Recherche Médicale, France; The Ministry... and other collaborators

Completed

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Ebola Virus Infection

United States, Guinea, Liberia, Sierra Leone
Tysana Pte Ltd

Completed

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Treatment of Acute Yellow Fever Virus Infection

Singapore
Centre Hospitalier Universitaire Saint Pierre

Active, not recruiting

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

HIV Infections | Yellow Fever Vaccine

Belgium
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Coalition for Epidemic Preparedness... and other collaborators

Completed

A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

Lassa Virus Infection

Belgium
National Institute of Allergy and Infectious Diseases...

Recruiting

Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

Ebola Virus Disease

Liberia
Cecile Tremblay
Merck Sharp & Dohme LLC; Dalhousie University; Université de Montréal; Coalition... and other collaborators

Active, not recruiting

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

Ebola

Canada
Najit Technologies, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Trial of an Inactivated Yellow Fever Virus Vaccine

Yellow Fever

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

Yellow Fever

United States, Uganda
Gamaleya Research Institute of Epidemiology and...

Unknown

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Ebola Virus Disease

Russian Federation
National Institute of Allergy and Infectious Diseases...

Suspended

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Ebola Virus Disease

United States
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Ebola Virus Infection | Filovirus Infections

United Kingdom
University of Aarhus
Martin Tolstrup

Enrolling by invitation

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination (CYF-8)

Healthy | Cytotoxicity | Yellow Fever Vaccination Reaction

Denmark
Nurhasan Agung Prabowo

Recruiting

Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever Patients

Dengue Fever

Indonesia
Kaohsiung Medical University Chung-Ho Memorial...
Centers for Disease Control and Prevention

Unknown

Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection

Dengue Fever

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Ebola and Marburg Virus Vaccines

Ebola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | Ebolavirus

United States
Takeda

Completed

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Dengue Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia (CYD00082)

Dengue Fever

Colombia
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of Dengue RDTs

Dengue Fever

Pakistan

Clinical Trials on Hemorrhagic Fevers, Viral

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations